Skip to main content

Advertisement

SpringerLink
Log in

Re Panoff et al., Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Panoff JE, Hrely J, Takita C, Reis IM, Zhao W, Sujoy V, Gomez CR, Jorda M, Koniaris I, Wright JL (2011) Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation. Breast Cancer Res Treat. doi:10.1007/s10549-011-1495-1

  2. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, Jager JJ, Hoogenraad WJ, Oei SB, Warlam-Rodenhuis CC, Pierart M, Collette L (2007) Impact of a higher radiation dose on local control and survival in breast conserving therapy of early breast cancer: 10 year results of the randomized boost versus no boost trial of EORTC 22881–10882 Trial. J Clin Oncol 25:3259–3265

    Article  PubMed  Google Scholar 

  3. Comen EA, Robson M (2010) Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer. Cancer J 16:48–52

    Article  PubMed  CAS  Google Scholar 

  4. Efimova EV, Mauceri HJ, Golden DW, Labay E, Bindokas VP, Darga TE, Chakraborty C, Barreto-Andrade JC, Crawley C, Sutton HG, Kron SJ, Weichselbaum RR (2010) Poly(ADP-ribose) polymerase inhibitor induces accelerated senescence in irradiated breast cancer cells and tumors. Cancer Res 70:6277–6282

    Article  PubMed  CAS  Google Scholar 

  5. Liu SK, Coackley C, Krause M, Jalali F, Chan N, Bristow RG (2008) A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia. Radiother Oncol 88(2):258–268

    Article  PubMed  CAS  Google Scholar 

  6. Taghian A, Jeong J-H, Mamounas E, Anderson S, Bryant J, Deutsch M, Wolmark N (2004) Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 22(21):4247–4254

    Article  PubMed  Google Scholar 

References for Rebuttal letter

  1. Panoff JE, Takita C, Hurley J et al (2011) Higher chest wall dose results in improved locoregional outcome in patients receiving postmastectomy radiation. Int J Radiat Oncol Biol Phys [Epub ahead of print]

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Cancer Care Centre, St George Hospital, Kogarah, 2217, Australia

    Peter Graham

Authors
  1. Peter Graham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Graham.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Graham, P. Re Panoff et al., Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation. Breast Cancer Res Treat 130, 353–355 (2011). https://doi.org/10.1007/s10549-011-1598-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-011-1598-8

Keywords

Search

Navigation